Fisher & Paykel Healthcare Corporation Limited Financials

Market Capitalization A$15.91 Billion as of July 1, 2024

Valuations Metrics as of May. 5, 2024

Trailing PE	62.93
Forward PE	50.59
Price to Sales TTM	A$8.93
Price to Book MRQ	A$8.57
Enterprise to Revenue	9.01
Enterprise to EBITDA	34.83

Financial Reports as of Mar. 31, 2023

Financials

Fiscal Year Ends	2023-03-31
Most Recent Quarter	2023-03-31
Profit Margin	15.45%
Operating Margin	18.99%
Return on Assets TTM	9.98%
Return on Equity TTM	16.20%

Income Statement

Revenue TTM	A$1,540,586,944
Revenue per Share TTM	A$2.92
Quarterly Revenue Growth	16.40%
Gross Profit TTM	A$945,900,000
EBITDA	A$433,700,000
Net Income to Common TTM	A$237,971,661
Diluted EPS TTM	A$0.41
Quarterly Earnings Growth YoY	11.90%

Balance Sheet

Total Cash MRQ	A$64,107,765
Total Cash per Share MRQ	A$0.12
Total Debt MRQ	A$
Total Debt to Equity MRQ	18.46
Current Ratio MRQ	2.54
Book Value per Share MRQ	A$3.01

Cash Flow

Operating Cash Flow TTM	A$357,184,824
Levered Free Cash Flow TTM	A$-79,986,936

FPH Stock Info as of May. 5, 2024

Stock Statistics

Shares Outstanding	582,169,984
Float Shares	579,864,993
Avg 10 Volume	425,118
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	9.41%
% Held by Institutions	37.66%

Stock Price Summary

Beta	0.41
Fifty Two Week Low	A$18.58
Fifty Two Week High	A$25.99
Fifty Two Week Change	2.91%
Day 50 MA	A$23.78
Day 200 MA	A$21.83

Dividends and Splits

Forward Annual Dividend Rate	A$0.67
Forward Annual Dividend Yield	2.60%
Trailing Annual Dividend Rate	A$0.33
Trailing Annual Dividend Yield	1.29%
Payout Ratio	79.61%
Dividend Date
Ex Dividend Date	2023-12-05
Last Split Factor
Last Split Date	2004-09-27